|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBOOKCENTRAL_ocn912321549 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
150608t20152015enka ob 001 0 eng d |
010 |
|
|
|a 2014955851
|
040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d EBLCP
|d OCLCF
|d OCLCQ
|d VT2
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCL
|d OCLCA
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|
015 |
|
|
|a GBB550589
|2 bnb
|
016 |
7 |
|
|a 101667031
|2 DNLM
|
019 |
|
|
|a 916923425
|a 1129365895
|a 1228562461
|
020 |
|
|
|a 9780191019968
|q (e-book)
|
020 |
|
|
|a 0191019968
|q (e-book)
|
020 |
|
|
|z 9780198709992
|
020 |
|
|
|a 0198709994
|q (pbk.)
|
020 |
|
|
|a 9780198709992
|
029 |
1 |
|
|a AU@
|b 000056112992
|
035 |
|
|
|a (OCoLC)912321549
|z (OCoLC)916923425
|z (OCoLC)1129365895
|z (OCoLC)1228562461
|
050 |
|
4 |
|a RC516
|b .N487 2015eb
|
060 |
0 |
0 |
|a 2015 H-776
|
060 |
1 |
0 |
|a WM 270
|
082 |
0 |
4 |
|a 616.895
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Neuroprogression and staging in bipolar disorder /
|c edited by Flavio Kapczinski [and three others].
|
250 |
|
|
|a First edition.
|
264 |
|
1 |
|a Oxford, England :
|b Oxford University Press,
|c 2015.
|
264 |
|
4 |
|c ©2015
|
300 |
|
|
|a 1 online resource (357 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Cover; Contents; 1 Clinical staging in bipolar disorder: a historical perspective; Robert M. Post; 2 Staging systems in bipolar disorder; Ralph W. Kupka, Manon H.J. Hillegers, and Jan Scott; 3 Allostatic load and accelerated ageing in bipolar disorder; Iria Grande and Flavio Kapczinski; 4 Neuroprogression and biological underpinnings of staging in bipolar disorder; Gabriel R. Fries, Pedro V.S. Magalhães, Flavio Kapczinski, and Michael Berk; 5 Functioning and illness progression in bipolar disorder; Adriane R. Rosa, Clarissa S. Gama, and Eduard Vieta.
|
505 |
8 |
|
|a 6 Cognition and illness progression in bipolar disorderAnabel Martinez-Aran, Caterina del Mar Bonnin, Carla Torrent, Brisa Solé, Imma Torres, and Esther Jiménez; 7 Social cognition and staging in bipolar disorder; Sergio Strejilevich and Diego Martino; 8 Affective temperaments: potential latent stages of bipolar disorders; Gustavo H. Vázquez and Xenia Gonda; 9 Neuroimaging and illness progression; Benicio N. Frey, Luciano Minuzzi, Bartholomeus C.M. Haarman, andRoberto B. Sassi; 10 Biomarkers of illness progression in bipolar disorder; Aroldo A. Dargél and Marion Leboyer.
|
505 |
8 |
|
|a 11 Childhood adversity and illness progression in bipolar disorderJoana Bücker, Marcia Kauer-Sant'Anna, and Lakshmi N. Yatham; 12 Vascular and metabolic medical comorbidities and neuroprogression in bipolar disorder; Anusha Baskaran, Benjamin I. Goldstein, and Roger McIntyre; 13 Substance misuse in staging bipolar affective disorder; Romain Icick and Frank Bellivier; 14 Excellent lithium responders, resilience, and staging in bipolar disorder; Janusz K. Rybakowski; 15 Staging and early intervention in bipolar disorder; Vicent Balanzá-Martínez, María Lacruz, and Rafael Tabarés-Seisdedos.
|
505 |
8 |
|
|a 16 Pharmacological treatment of late-stage bipolar disorderAline André Rodrigues and Mauricio Kunz; 17 Illness progression and psychosocial interventions in bipolar disorder; María Reinares and Francesc Colom; 18 Staging systems in bipolar disorder: current findings, future directions, and implications for clinical practice; Flavio Kapczinski, Eduard Vieta, Pedro V.S. Magalhães, and Michael Berk; Index.
|
520 |
|
|
|a After the original proposals of staging for psychotic disorders developed by McGorry and colleagues, a few systems have been put forward specifically for people with bipolar disorder. There is now consistent evidence that, at least for a significant portion of people with this disease, clinical course and outcome are not as benign as initially described. The evidence thus far points to relevant differences between early and late stages of bipolar disorders in theclinical course of illness, neurobiology and systemic pathology. These differences all suggest that staging is a viable addition to c.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Bipolar disorder.
|
650 |
|
0 |
|a Biochemical markers.
|
650 |
1 |
2 |
|a Bipolar Disorder
|
650 |
2 |
2 |
|a Biomarkers
|
650 |
2 |
2 |
|a Disease Progression
|
650 |
|
6 |
|a Troubles bipolaires.
|
650 |
|
6 |
|a Marqueurs biologiques.
|
650 |
|
7 |
|a Biochemical markers
|2 fast
|
650 |
|
7 |
|a Bipolar disorder
|2 fast
|
700 |
1 |
|
|a Kapczinski, Flavio,
|e editor.
|
758 |
|
|
|i has work:
|a Neuroprogression and staging in bipolar disorder (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGQDPTh4jjQc7Wgg34qVcq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Neuroprogression and staging in bipolar disorder.
|b First edition.
|d Oxford, England : Oxford University Press, ©2015
|h xii, 344 pages
|z 9780198709992
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=2066681
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL2066681
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr11061373
|
994 |
|
|
|a 92
|b IZTAP
|